Study of the Interactions Between Dientamoba Fragilis and the Gut Microbiota

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

27 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-02-16

Study Completion Date

2019-03-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

D.fragilis is an intestinal protozoon that feeds by phagocytosis of intestinal bacteria. The study aim to determine if the carriage of the intestinal parasite D.fragilis is associated to changes of gut microbiota in subjects presenting with or without intestinal symptoms.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms

NCT06524791

Gastroenteritis

NOT_YET_RECRUITING

Profiling Fecal Samples for Selection of Donors of Feces

NCT04078581

Fecal Microbiota Transplantation

WITHDRAWN NA

The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation

NCT03621657

Clostridium Difficile Infection C.Difficile Diarrhea CDI

COMPLETED PHASE2

Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscopic Screening for Digestive Cancer in the University Hospital of Saint-Etienne

NCT02502474

STAPHYLOCOCCAL INFECTIONS

COMPLETED NA

Digestive Microbiota Transplant

NCT03606031

Clostridium Difficile Antibiotic Resistant Infection Chronic Diarrhea of Unknown Origin

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diarrhea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Symptomatic subjects

Subjects with intestinal symptoms

Stool sampling and sequencing of gut microbiota.

Intervention Type OTHER

Asymptomatic subjects

Subjects without intestinal symptoms

Stool sampling and sequencing of gut microbiota.

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stool sampling and sequencing of gut microbiota.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male/female aged at least of 18 years
* subject with abdominal pain, diarrhea, bloating
* no other known intestinal disease

* male/female aged at least of 18 years
* no known intestinal disease

Exclusion Criteria

* chronic intestinal diseases such as IBD, IBS …
* intake of antibiotic or probiotic within the 2 last months
* subject in exclusion period
* subject unable to understand information for a free consent to the study
* subject in safeguarding justice or guardianship

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes